← Back to Search

Behavioural Intervention

Wakaya Program for Childhood Obesity (Wakaya Trial)

N/A
Recruiting
Led By Karina Walters, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline; post-intervention (month 3); 3 months post (month 6); 6 months post-intervention (month 9)
Awards & highlights
No Placebo-Only Group

Summary

This trial assesses the effect of a Choctaw-based program on physical activity, eating habits, and drug/alcohol use to improve health.

Who is the study for?
The Wakaya trial is for high school students living in the Choctaw Nation of Oklahoma region who have unhealthy diets or sedentary lifestyles, and are not highly active outdoors. It's not for those with severe allergies, certain disabilities, a history of aggressive behavior, inability to follow directions, or recent opioid/methamphetamine use.
What is being tested?
This study tests the 'Wakaya: Rising Up for Choctaw Youth Health' program which aims to boost physical activity and healthy eating while reducing drug use among youth through outdoor activities and leadership skills development based on Choctaw values.
What are the potential side effects?
Since Wakaya is a lifestyle intervention program focusing on exercise and nutrition rather than medication, it does not have typical medical side effects. However, participants may experience fatigue or muscle soreness from increased physical activity.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline; post-intervention (month 3); 3 months post (month 6); 6 months post-intervention (month 9)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline; post-intervention (month 3); 3 months post (month 6); 6 months post-intervention (month 9) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in beverage habits over time
Change in food and beverage habits over time
Change in physical activity assessed by self-report
+2 more
Secondary study objectives
Body Mass Index (BMI) change
Change in alcohol use over time
Change in drug and alcohol refusal self-efficacy
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Wakaya (Immediate Group)Experimental Treatment1 Intervention
Participants in the immediate group will be randomly assigned to start the intervention immediately in the Spring.
Group II: Wait List ControlExperimental Treatment1 Intervention
Participants in the Wait List group will be randomly assigned to start the intervention 3 months later in the Summer.

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,820 Previous Clinical Trials
1,914,497 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,589 Previous Clinical Trials
3,328,341 Total Patients Enrolled
Karina Walters, PhDPrincipal InvestigatorUniversity of Washington

Media Library

Wakaya: Rising Up for Choctaw Youth Curriculum (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05818384 — N/A
Sedentary Lifestyle Research Study Groups: Wait List Control, Wakaya (Immediate Group)
Sedentary Lifestyle Clinical Trial 2023: Wakaya: Rising Up for Choctaw Youth Curriculum Highlights & Side Effects. Trial Name: NCT05818384 — N/A
Wakaya: Rising Up for Choctaw Youth Curriculum (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05818384 — N/A
~106 spots leftby Apr 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top